Guobang Pharma (605507.SS) Earnings Analysis
Guobang Pharma (605507.SS) has no confirmed upcoming earnings date. Trailing P/E 11.60.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 605507.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 605507.SS. This page updates as the calendar is published.
605507.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-16 | 0.29 CNY | n/a | n/a | n/a |
| 2026-03-27 | 0.27 CNY | n/a | n/a | n/a |
| 2025-10-16 | 0.39 CNY | n/a | n/a | n/a |
| 2025-07-30 | 0.44 CNY | n/a | n/a | n/a |
| 2025-04-15 | 0.38 CNY | n/a | n/a | n/a |
| 2024-10-18 | 0.3153 CNY | n/a | n/a | n/a |
| 2024-08-29 | 0.3725 CNY | n/a | n/a | n/a |
605507.SS valuation and analyst view
| Trailing P/E | 11.60 |
|---|---|
| Trailing EPS | 1.384 CNY |
| Price / book | 1.02 |
| Dividend yield | 3.72% |
| Market cap | 12.73B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Guobang Pharma (605507.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 605507.SS. This page updates as the calendar is published.
Did 605507.SS beat earnings last quarter?
Consensus estimate data was not available for 605507.SS's 2026-04-16 report.
What is 605507.SS's current P/E ratio and EPS?
605507.SS trades at a trailing P/E of 11.60 on trailing EPS of 1.383786535303243 CNY.
What do analysts rate 605507.SS?
605507.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.